Loading, Please Wait...
DENVER, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Healthcare technology firm Gofire™, an innovator of hardware and software solutions that aid in dose delivery, health tracking, and medication management via connected devices, announced today it has launched its long-anticipated metered-dose Inhaler following nearly five years of research, development, refinement and testing.
“Today we are proud to deliver the world’s most precise inhaler device to a public demanding a safe, scientifically backed system for the use of plant-based medicine,” said Peter Calfee, CEO of Gofire. “Amid nationwide safety concerns about vaporizers, we are humbled to bring our technology to a market that clearly recognizes the benefits of this drug delivery method but has few, if any, safe and reliable ways to approach it. Our Gofire Inhaler offers the most accurate, metered-dose experience available for plant medicine while providing protections against the conditions that have created health concerns among vaporization users.”
The Gofire Inhaler features revolutionary technologies that transform the delivery of inhaled, vaporized medicine, including:
“Consumers are rightfully concerned about contaminants in medicine like heavy metals, as well as additives like Vitamin E Acetate and Propylene Glycol,” Calfee said. “We understood five years ago that these issues could create dangerous health concerns in vaporizers, and it’s exactly why we’ve spent the time and resources to develop a pulmonary drug delivery platform that eliminates these issues.”
As part of its rigorous development process, the Gofire Inhaler has been proving itself as an effective tool for medical dose management throughout 2019. In March, Gofire launched its Beta Testing Program with 60 patients using the Inhaler to manage a wide variety of conditions. In July Colorado State University and Gofire announced the launch of a three-stage clinical trials study, becoming the first study in the nation to utilize objective, precise technology to accurately evaluate plant-based medicine intake, record chemical profiles and to monitor health outcomes.
Initial accolades for the Gofire Inhaler’s capabilities have come from a wide variety of sources:
“We’re gratified by the response we’ve received thus far, particularly from patients who have shared with us how much the Inhaler helps them manage their conditions,” Calfee said. “We can’t wait to start hearing from others as more people benefit from the ability to accurately dose, track and manage their use of plant-based medicines.”
The result of countless hours of R&D, backed by intelligence from researchers and healthcare professionals, the Gofire Inhaler gives patients control over their health by administering precise doses of plant-based medicine concentrates at customized temperature settings, while allowing them to easily track data, personal outcomes and desired effects through the Gofire personal dosing application. Together, the Gofire Inhaler and Gofire App create a “smart health ecosystem” enabling the precise dosage and replicable experience patients and physicians have been seeking from alternative medicines. The Gofire Inhaler is available now for $299 via Gofire’s website (https://gofire.co) and at select retailers and physicians offices.
If you are a technology or innovation writer, contact email@example.com to inquire about receiving a demo Gofire Inhaler to review.
Gofire is a healthcare technology company developing a proprietary smart inhaler that pairs with a personal dosing app to allow patients to create consistent experiences with plant-based medicines. By removing the fear of taking too much while gaining the support of crowdsourced data, Gofire users find products best suited to their specific needs. Gofire is committed to making health resources safe and accessible through standardizing dose regimens by delivery method and by patient condition. Gofire is helping people realize the medicinal and therapeutic benefits of alternative health products through a new take on wellness innovation. Visit their website here, and follow Gofire on Facebook, Instagram and Twitter.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/97ab9d55-5f59-4a52-bcbd-2bfc4ee58c26
A video accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/a9717523-d71a-4575-936a-a8621b4dc432